Statements (47)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
medication
|
| gptkbp:activeDuring |
ramipril
|
| gptkbp:availableIn |
generic
|
| gptkbp:clinicalTrials |
Phase III
diabetes management renal protection cardiovascular outcomes |
| gptkbp:contraindication |
pregnancy
angioedema history |
| gptkbp:dosageForm |
capsule
|
| gptkbp:drugInterdiction |
true
ACE inhibitor |
| gptkbp:endOfLife |
13 to 17 hours
|
| gptkbp:healthcare |
do not discontinue abruptly
avoid potassium-rich foods report any signs of allergic reaction take at the same time each day |
| https://www.w3.org/2000/01/rdf-schema#label |
Altace
|
| gptkbp:interactsWith |
NSAIDs
lithium diuretics potassium supplements |
| gptkbp:is_monitored_by |
blood pressure
renal function potassium levels |
| gptkbp:manufacturer |
gptkb:AstraZeneca
|
| gptkbp:maxRange |
10 mg once daily
|
| gptkbp:numberOfStudents |
renal
|
| gptkbp:nutritionalValue |
liver
|
| gptkbp:patentMaintenanceFee |
1991
|
| gptkbp:route |
oral
|
| gptkbp:sells |
ramipril
|
| gptkbp:sideEffect |
dizziness
fatigue nausea cough hyperkalemia |
| gptkbp:skills |
10 mg
5 mg 15 mg 2.5 mg 1.25 mg |
| gptkbp:startsAt |
2.5 mg once daily
|
| gptkbp:type |
ramipril
|
| gptkbp:usedFor |
hypertension
heart failure |
| gptkbp:waterManagement |
urine
|